Direct Biologics, LLC   Report issue

For profit Phase 2
Founded: Austin TX United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04493242
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Direct Biologics, LLC